ELOXX PHARMACEUTICALS, INC. Debt Conversion, Original Debt, Amount
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Debt Conversion, Original Debt, Amount of $1.06 million for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2026-09-11
- ELOXX PHARMACEUTICALS, INC. debt conversion, original debt, amount for the quarter ending 2026-06-30 was $0.00.
- ELOXX PHARMACEUTICALS, INC. debt conversion, original debt, amount for the quarter ending 2026-03-31 was $1.06M.
- ELOXX PHARMACEUTICALS, INC. debt conversion, original debt, amount for the quarter ending 2025-06-30 was $0.00.
- ELOXX PHARMACEUTICALS, INC. debt conversion, original debt, amount for the quarter ending 2025-03-31 was $0.00.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: S-1 6 month − S-1/A 3 month · filed 2026-09-11 | $1.06M S-1 · filed 2026-09-11 | |
| 2026-03-31 | $1.06M S-1/A · filed 2026-06-04 | ||
| 2025-12-31 | $8.50M S-1 · filed 2026-09-11 | ||
| 2025-06-30 | $0.00 derived: S-1 6 month − S-1/A 3 month · filed 2026-09-11 | $0.00 S-1 · filed 2026-09-11 | |
| 2025-03-31 | $0.00 S-1/A · filed 2026-06-04 | ||
| 2024-12-31 | $0.00 S-1 · filed 2026-09-11 | ||
| 2023-12-31 | $0.00 S-1 · filed 2026-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |